Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bayer AG sell goldmanns

Start price
€33.59
27.12.23 / 0%
Target price
-
27.12.24
Performance (%)
-42.84%
End price
€19.20
28.12.24
Summary
This prediction ended on 28.12.24 with a price of €19.20. goldmanns correctly predicted massive losses of -42.84% for Bayer AG. Dividends of €0.12 are taken into consideration when calculating the performance. This prediction was marked as speculative and is excluded from goldmanns's performance statistics.

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w 1m 1y
Bayer AG -4.544% -4.544% 82.234%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by goldmanns for this prediction

In the thread Bayer AG diskutieren

Sell Bayer AG

In the thread Trading Bayer AG
Prediction Sell
Perf. (%) -42.84%
Target price
Change
Ends at 27.12.24

Die von goldmanns gewählte maximale Laufzeit wurde überschritten